MRI/ULTASOUND FUSION INCREASE DIAGNOSTIC ACCURACY OF BREAST LESION

Background: Breast cancer is the most common malignancy among women worldwide, and early and accurate detection is critical for effective treatment. While magnetic resonance imaging (MRI) and ultrasound (US) are widely used for breast cancer diagnosis, each modality has inherent limitations. MRI/ultrasound fusion imaging combines the strengths of both techniques, offering enhanced diagnostic capabilities. Objective: This study evaluates the impact of MRI/ultrasound fusion imaging on the diagnostic accuracy of breast cancer, focusing on lesion localization, characterization, and clinical utility in guiding biopsy and treatment planning. Methods: A retrospective analysis was conducted on 59 patients with suspicious breast lesions who underwent both MRI and ultrasound imaging. MRI/ultrasound fusion imaging was performed to combine high-resolution MRI data with real-time ultrasound. Diagnostic accuracy, sensitivity, and specificity were compared across standalone MRI, ultrasound, and fusion imaging. Results: MRI/ultrasound fusion imaging demonstrated significantly higher diagnostic accuracy (89.8%) compared to MRI (84.7%) and ultrasound (81.3%) alone. Sensitivity and specificity for fusion imaging were 97.9% and 58.3%, respectively. It also facilitated real-time targeted biopsy with improved precision. Conclusion: MRI/ultrasound fusion imaging significantly enhances the diagnostic accuracy of breast cancer detection . MRI/ultrasound fusion imaging may be a valuable tool for clinical practice.